Canada Hemp Regulations: Licensing, THC Limits, and Compliance Guide

Executive Summary

Canada's industrial hemp regulations are undergoing a comprehensive review by Health Canada as of May 2026, marking the most significant policy examination since the Cannabis Act integrated hemp oversight in 2018. The review aims to streamline licensing requirements, reduce administrative burdens for farmers, and modernize THC testing protocols that have constrained the sector's growth. Canada operates under a dual regulatory framework where hemp cultivation falls under the Cannabis Act while food and cosmetic products remain subject to separate federal oversight. The country maintains a 0.3% THC threshold for industrial hemp, aligning with international standards adopted by the United States in 2018. This regulatory modernization comes as Canada's hemp industry generates approximately $140 million CAD annually in farm gate value, with over 84,000 acres cultivated in 2025. The review addresses persistent industry complaints about licensing delays, costly compliance requirements, and testing protocols that fail to distinguish between psychoactive delta-9-THC and non-intoxicating cannabinoids. Stakeholders include approximately 500 licensed hemp farmers, processors serving domestic and export markets, Health Canada's Cannabis Directorate, Agriculture and Agri-Food Canada, and provincial agriculture ministries that implement federal standards.

Why This Matters

The regulatory review affects a $500 million CAD hemp supply chain spanning seed production, fiber processing, food manufacturing, and emerging CBD markets. Canada ranks among the top five global hemp producers by acreage, with Saskatchewan and Manitoba accounting for 75% of national cultivation. The outcome will determine whether Canadian farmers can compete with American producers who gained regulatory clarity through the 2018 Farm Bill, which removed hemp from the Controlled Substances Act. For farmers, the current licensing system imposes costs of $1,580 CAD per site annually, with applications requiring 60-90 days for approval. These delays force growers to plant late or miss optimal growing windows entirely. The review could reduce fees, accelerate approvals, and eliminate redundant inspections that currently require both pre-harvest and post-harvest THC testing. Processors face uncertainty around CBD extraction and product formulation. While Health Canada permits CBD derived from hemp in natural health products, the approval pathway requires clinical trials costing $500,000 to $2 million CAD per product. The review may establish a simplified notification system for low-risk CBD products, similar to frameworks in the European Union. Export markets represent the highest stakes. Canada ships hemp seed to the United States, European Union, and Asia, generating $85 million CAD in annual export value. Regulatory harmonization with U.S. standards would eliminate trade friction and allow Canadian genetics companies to serve American farmers directly. Conversely, maintaining stricter requirements could disadvantage Canadian producers as global markets expand. Provincial governments in Saskatchewan, Manitoba, and Alberta have advocated for regulatory reform since 2022, arguing that hemp offers crop rotation benefits and economic diversification for grain farmers. Indigenous communities in northern regions view hemp as a potential cash crop for remote areas with limited agricultural options.

Background and History

Canada's hemp regulations evolved through three distinct eras: prohibition (1938-1998), controlled licensing (1998-2018), and Cannabis Act integration (2018-present).

Prohibition Era (1938-1998)

Hemp cultivation became illegal in Canada in 1938 under the Opium and Narcotic Drug Act, which classified all Cannabis sativa varieties as narcotics regardless of THC content. The prohibition mirrored U.S. policy shifts driven by the Marihuana Tax Act of 1937. For six decades, Canadian farmers could not legally grow hemp despite its historical use for rope, textiles, and paper production. The prohibition ended through advocacy by the Hemp Industry Association of Canada, formed in 1994. Researchers at the University of Manitoba and University of Saskatchewan demonstrated that low-THC hemp varieties posed no intoxication risk and offered agronomic benefits for Prairie farmers. In 1994, Health Canada authorized limited research plots under strict supervision.

Controlled Licensing (1998-2018)

Health Canada established the Industrial Hemp Regulations in 1998 under the Controlled Drugs and Substances Act. The regulations legalized commercial cultivation for the first time in 60 years, subject to licensing requirements. Key provisions included: - THC threshold of 0.3% in flowering heads and leaves, measured on a dry-weight basis - Mandatory use of certified seed varieties approved by the Canadian Food Inspection Agency - Criminal background checks for all license applicants - Site-specific licenses requiring GPS coordinates and field maps - Pre-harvest THC testing conducted by Health Canada inspectors - Prohibition on flowering head sales except to licensed processors The 1998 regulations launched Canada's modern hemp industry. By 2000, farmers cultivated 20,000 acres, primarily in Manitoba. Acreage peaked at 140,000 acres in 2017 as demand for hemp hearts (hulled seeds) surged in North American health food markets. However, the system created bottlenecks. Health Canada's small inspection team struggled to test fields before harvest, forcing farmers to wait weeks for results. If THC levels exceeded 0.3%, farmers had to destroy entire crops. The testing protocol measured total THC rather than delta-9-THC, penalizing varieties with high THCA (tetrahydrocannabinolic acid) that converts to THC only when heated.

Cannabis Act Integration (2018-Present)

The Cannabis Act, which legalized adult-use cannabis on October 17, 2018, absorbed hemp regulation into a unified framework. The Industrial Hemp Regulations were repealed and replaced by provisions within the Cannabis Regulations (SOR/2018-144). Hemp became defined as cannabis plants and plant parts containing 0.3% THC or less. The integration aimed to simplify oversight by consolidating all cannabis-related activities under one statute. In practice, it created confusion. Hemp farmers suddenly fell under the same regulatory umbrella as cannabis cultivators, requiring security clearances and compliance with cannabis tracking systems. License fees increased from $250 CAD to $1,580 CAD per site annually. The Cannabis Act preserved the 0.3% THC threshold but introduced new requirements: - Mandatory participation in the Cannabis Tracking System (CTS), a seed-to-sale database - Enhanced security measures including fencing and surveillance cameras for outdoor fields - Restrictions on hemp flower sales, limiting them to licensed processors only - Prohibition on CBD extraction by farmers, reserving it for licensed processors with separate authorizations Industry groups protested the increased burden. The Canadian Hemp Trade Alliance, formed in 2019, argued that hemp farmers should not face the same scrutiny as cannabis producers. In 2020, Health Canada issued a policy statement clarifying that outdoor hemp fields did not require the same security measures as indoor cannabis facilities, but confusion persisted.

Recent Developments (2022-2026)

In June 2022, Agriculture and Agri-Food Canada released a hemp sector profile identifying regulatory complexity as the primary barrier to growth. The report noted that U.S. hemp acreage had surpassed Canada's following the 2018 Farm Bill, reversing a historical advantage. In November 2023, Health Canada launched a public consultation on cannabis regulations, including hemp provisions. The consultation received 187 submissions, with 92% of hemp-related comments requesting streamlined licensing, reduced fees, and revised THC testing protocols. In March 2024, the Standing Committee on Agriculture and Agri-Food issued a report titled "Growing Forward: Opportunities for Canada's Hemp Industry." The committee recommended: - Separating hemp regulation from psychoactive cannabis oversight - Adopting delta-9-THC testing instead of total THC - Reducing license fees to $500 CAD per site - Allowing farmers to sell hemp flower directly to processors without additional authorizations - Establishing a 30-day license approval standard Health Canada responded in September 2024, committing to a comprehensive regulatory review by mid-2026. The May 2026 announcement fulfills that commitment, initiating a formal review process expected to conclude with proposed amendments by early 2027.

Key Players

Health Canada

Health Canada's Cannabis Directorate administers hemp licensing and compliance through its Industrial Hemp Program. The directorate employs approximately 40 staff dedicated to hemp oversight, including inspectors who conduct field testing. Dr. Supriya Sharma, Chief Medical Advisor, oversees cannabis policy development. The directorate balances public health mandates with economic development goals, often prioritizing safety over industry convenience.

Agriculture and Agri-Food Canada

Agriculture and Agri-Food Canada (AAFC) provides research funding, market development support, and policy analysis for hemp. The department operates research stations in Manitoba and Saskatchewan that develop hemp varieties and agronomic practices. AAFC advocates for regulatory reform to enhance competitiveness but defers to Health Canada on licensing decisions.

Canadian Hemp Trade Alliance

The Canadian Hemp Trade Alliance represents farmers, processors, and seed companies. The organization submitted detailed recommendations during the 2023 consultation, emphasizing the need for risk-proportionate regulation. Executive Director Rielle Capler has testified before parliamentary committees, arguing that hemp poses minimal public health risk and should not be regulated as strictly as psychoactive cannabis.

Provincial Agriculture Ministries

Saskatchewan's Ministry of Agriculture has been the most vocal provincial advocate for reform. Saskatchewan accounts for 45% of Canadian hemp acreage, with approximately 38,000 acres cultivated in 2025. The ministry argues that licensing delays cost farmers $12 million CAD annually in lost planting windows. Manitoba and Alberta have echoed these concerns, while Ontario and Quebec focus on hemp food product development.

Hemp Genetics International

Hemp Genetics International, based in British Columbia, is Canada's largest hemp seed producer. The company breeds varieties optimized for seed, fiber, and CBD content. CEO Shaun Crew has criticized THC testing protocols that penalize high-THCA varieties, which offer superior agronomic traits. The company exports seed to 14 countries and views regulatory harmonization as essential for market access.

Manitoba Harvest

Manitoba Harvest, a subsidiary of Tilray Brands, is North America's largest hemp food manufacturer. The company processes 35,000 metric tons of hemp seed annually into hemp hearts, protein powder, and oil. Manitoba Harvest supports streamlined regulations but opposes loosening THC limits, fearing that higher thresholds could trigger food safety concerns in export markets.

Legal and Regulatory Framework

Canada's hemp regulations operate under the Cannabis Act (S.C. 2018, c. 16) and the Cannabis Regulations (SOR/2018-144), with additional oversight from the Food and Drugs Act (R.S.C., 1985, c. F-27) for consumable products.

Cannabis Act Provisions

Section 2 of the Cannabis Act defines "industrial hemp" as cannabis plants or plant parts that contain 0.3% or less THC. This definition determines whether a plant falls under hemp or cannabis licensing requirements. Section 62 authorizes the Governor in Council to make regulations respecting industrial hemp, including licensing, security, and record-keeping requirements. Section 8 prohibits possession of cannabis except as authorized by the Act or regulations. This provision technically criminalizes possession of hemp flower by unlicensed individuals, though Health Canada has indicated it does not enforce this provision against farmers handling their own crops.

Cannabis Regulations

Part 14 of the Cannabis Regulations (sections 235-252) governs industrial hemp licensing. Key requirements include: - License applications must include site plans, security measures, and criminal record checks (section 237) - Licenses are valid for one year and cost $1,580 CAD per site (section 238) - Licensees must use certified seed listed in the List of Approved Cultivars maintained by the Canadian Food Inspection Agency (section 241) - Licensees must report planting dates, harvest dates, and crop destruction to Health Canada within 30 days (section 245) - THC testing must occur within 30 days before harvest, using flowering heads and leaves (section 247) - Crops exceeding 0.3% THC must be destroyed under Health Canada supervision (section 248) Section 243 requires participation in the Cannabis Tracking System, a federal database tracking all cannabis and hemp cultivation, processing, and sales. Farmers must report monthly inventory data, creating administrative burdens that grain farmers do not face for other crops.

Food and Drugs Act

Hemp-derived food products fall under the Food and Drugs Act and the Food and Drug Regulations (C.R.C., c. 870). Health Canada permits hemp seed, hemp seed oil, and hemp seed protein in foods without pre-market approval, provided they meet safety standards. However, CBD and other cannabinoids require authorization as natural health products under the Natural Health Products Regulations (SOR/2003-196). The dual regulatory system creates confusion. A hemp seed product requires only standard food safety compliance, but adding CBD extract triggers natural health product requirements including clinical trials, good manufacturing practices certification, and product-specific licensing.

Provincial Legislation

Provinces regulate hemp indirectly through agricultural land use, crop insurance, and food safety inspection. Saskatchewan's Agri-Food Act, 2004 (S.S. 2004, c. A-15.21) authorizes the province to establish crop insurance programs for hemp, treating it as an agricultural commodity. Quebec's Loi sur les produits alimentaires (RLRQ, c. P-29) imposes additional labeling requirements for hemp food products sold in the province.

International Obligations

Canada is a signatory to the 1961 Single Convention on Narcotic Drugs, which classifies cannabis as a Schedule I and Schedule IV substance. Article 28 of the Convention permits industrial hemp cultivation for fiber and seed production but requires parties to establish control measures preventing diversion to drug use. Canada's 0.3% THC threshold and licensing system fulfill these treaty obligations. The United States-Mexico-Canada Agreement (USMCA), which entered into force on July 1, 2020, does not specifically address hemp. However, Chapter 3 (Agriculture) and Chapter 9 (Sanitary and Phytosanitary Measures) establish frameworks for resolving trade disputes over agricultural products. Regulatory divergence between Canada and the United States could trigger trade challenges if one country's standards create non-tariff barriers.

Current Regulatory Requirements

Hemp farmers in Canada must navigate a multi-stage licensing process that begins four months before planting and extends through post-harvest reporting.

Stage	Requirement	Timeline	Cost
Pre-Application	Criminal record check, site plan preparation, seed variety selection	60-90 days before planting	$100 CAD (background check)
License Application	Submit application via Health Canada portal with GPS coordinates, field maps, security measures	60 days before planting	$1,580 CAD per site
License Approval	Health Canada review and approval	60-90 days processing time	No additional cost
Planting	Use certified seed from approved cultivar list; report planting date within 30 days	May-June (varies by region)	Seed cost: $3-5 CAD per pound
Pre-Harvest Testing	Notify Health Canada 30 days before anticipated harvest; inspector collects samples	August-September	No direct cost; delays if inspector unavailable
Harvest	Await test results (7-14 days); harvest only if THC ≤0.3%	September-October	Crop destruction if over 0.3% THC
Post-Harvest	Report harvest date, yield, and disposition within 30 days	Within 30 days of harvest	No additional cost
Annual Reporting	Submit annual report via Cannabis Tracking System	Within 30 days of license expiry	No additional cost

The most contentious requirement is pre-harvest THC testing. Health Canada inspectors collect samples from flowering heads and leaves, which are analyzed at the department's laboratory in Ottawa. The testing protocol measures total THC, including THCA, using gas chromatography. This method applies heat, converting THCA to delta-9-THC and inflating results. A plant with 0.2% delta-9-THC and 0.5% THCA would test at approximately 0.6% total THC, exceeding the legal limit despite containing minimal psychoactive cannabinoids. Farmers in remote areas face additional challenges. Inspectors may require multiple days to reach distant fields, delaying harvest during narrow weather windows. If rain arrives before testing, crops may deteriorate, reducing quality and market value.

Market and Business Implications

Canada's hemp industry generated $140 million CAD in farm gate value in 2025, with downstream processing and manufacturing adding $360 million CAD in economic activity.

Cultivation Economics

Hemp production costs range from $400 to $600 CAD per acre, including seed, fertilizer, and equipment. Grain hemp (grown for seed) yields 800-1,200 pounds per acre, selling for $0.60-$0.90 CAD per pound to processors. Gross revenue averages $720 CAD per acre, with net returns of $120-$320 CAD per acre depending on yield and market prices. Fiber hemp requires specialized harvesting and processing equipment, limiting adoption. Only 3% of Canadian hemp acreage targets fiber markets. Dual-purpose varieties that produce both seed and fiber offer higher returns but require coordination with processors who can handle both products.

Processing and Manufacturing

Manitoba Harvest dominates hemp food processing, controlling approximately 40% of North American hemp heart production. The company sources seed from Canadian and U.S. farmers, processing it into hulled seed, protein powder, and oil. Hemp hearts retail for $15-$25 CAD per pound, representing a 20-fold markup over farm gate prices. Smaller processors focus on niche markets. Hemp Oil Canada produces cold-pressed hemp seed oil for cosmetics and supplements. Hempco Food and Fiber processes hemp into animal feed and industrial fiber products. These companies employ 500-700 workers across Manitoba, Saskatchewan, and Alberta.

CBD Market Uncertainty

CBD extraction from hemp remains economically unviable under current regulations. While Health Canada permits CBD in natural health products, the approval process requires clinical trials demonstrating safety and efficacy. Only three hemp-derived CBD products have received natural health product numbers since 2018, all from large pharmaceutical companies with million-dollar research budgets. In contrast, the United States allows CBD in dietary supplements without pre-market approval, creating a $2 billion USD market. Canadian companies cannot compete, losing potential export opportunities. The regulatory review may establish a simplified pathway for low-dose CBD products (e.g., 10-25 mg per serving) that pose minimal risk.

Export Markets

Canada exported 45,000 metric tons of hemp seed in 2025, valued at $85 million CAD. The United States is the largest destination, accounting for 60% of exports. European Union countries import Canadian hemp seed for food and bird feed. China and South Korea purchase smaller volumes for traditional medicine applications. Regulatory harmonization with the United States would expand export opportunities. Currently, Canadian seed must meet both Canadian and U.S. standards, requiring dual testing and certification. If both countries adopted identical THC thresholds and testing protocols, cross-border trade would become seamless.

Investment and Capital Flows

Hemp attracts minimal venture capital compared to psychoactive cannabis. Since 2018, Canadian hemp companies raised $45 million CAD in equity financing, compared to $8 billion CAD for cannabis companies. Investors cite regulatory uncertainty and low margins as deterrents. However, established agricultural companies are entering the sector. Nutrien, Canada's largest fertilizer producer, launched a hemp-specific product line in 2024. Richardson International, a major grain handler, began contracting hemp acreage in Saskatchewan, providing farmers with forward contracts and agronomic support.

What Experts Say

Industry stakeholders, researchers, and policymakers have articulated divergent views on regulatory reform priorities. Rielle Capler of the Canadian Hemp Trade Alliance argues that hemp should be regulated as an agricultural commodity rather than a controlled substance. According to Capler, the current system imposes costs and delays that prevent farmers from competing with U.S. producers who face fewer restrictions. Capler advocates for a notification-based system where farmers register their intent to grow hemp without requiring annual licenses. Dr. Andrew Bates, a plant scientist at the University of Manitoba, emphasizes the need for delta-9-THC testing instead of total THC. According to Bates, THCA poses no intoxication risk and should not count toward the 0.3% threshold. Bates' research demonstrates that many high-performing hemp varieties exceed 0.3% total THC due to THCA content but remain below 0.3% delta-9-THC. Adopting delta-9-THC testing would expand the genetic pool available to farmers, improving yields and disease resistance. Shaun Crew of Hemp Genetics International supports regulatory harmonization with the United States. According to Crew, divergent standards create trade barriers and prevent Canadian seed companies from serving American farmers. Crew notes that U.S. states increasingly adopt 1% total THC thresholds for hemp, while Canada maintains 0.3%. This discrepancy limits market access for Canadian genetics. Dr. Supriya Sharma of Health Canada has stated that any regulatory changes must maintain public health protections and fulfill Canada's international treaty obligations. According to Sharma, the 0.3% THC threshold aligns with the 1961 Single Convention on Narcotic Drugs and provides a clear bright line between hemp and cannabis. Sharma has indicated openness to streamlining licensing processes but cautions against loosening THC limits without scientific evidence supporting safety. The Canadian Federation of Agriculture, representing 200,000 farmers, supports reducing license fees and accelerating approval timelines. According to the federation, hemp offers crop rotation benefits and economic diversification, particularly for Prairie grain farmers facing volatile commodity markets. The federation has not taken a position on THC testing protocols, deferring to agronomic experts. Provincial agriculture ministers from Saskatchewan, Manitoba, and Alberta issued a joint statement in April 2026 urging Health Canada to prioritize regulatory reform. According to the statement, hemp represents a $500 million CAD opportunity that current regulations stifle. The ministers requested a 30-day license approval standard, reduced fees, and elimination of pre-harvest testing for farmers with compliance histories.

What's Next

Health Canada's regulatory review will unfold over 18-24 months, with proposed amendments expected by early 2027 and final regulations by late 2027 or early 2028. The review process includes three phases: 1. **Stakeholder Consultation (May-August 2026)**: Health Canada will solicit written submissions from farmers, processors, researchers, and provincial governments. The department will host virtual town halls in June and July 2026, allowing stakeholders to present recommendations. The consultation will address licensing requirements, THC testing protocols, fees, and CBD product pathways. 2. **Policy Development (September 2026-March 2027)**: Health Canada will analyze submissions and draft proposed regulatory amendments. The department will consult with Agriculture and Agri-Food Canada, the Canadian Food Inspection Agency, and provincial agriculture ministries to ensure alignment across federal and provincial jurisdictions. Legal review will confirm that proposed changes comply with the Cannabis Act and international treaties. 3. **Public Comment and Finalization (April-December 2027)**: Health Canada will publish proposed amendments in the Canada Gazette, Part I, triggering a 75-day public comment period. The department will review comments, make final revisions, and publish final regulations in the Canada Gazette, Part II. Regulations typically take effect 60 days after publication, meaning changes could be implemented by early 2028. Key decision points include: - **THC Testing Protocol**: Will Health Canada adopt delta-9-THC testing, or maintain total THC measurement? This decision affects genetic diversity and crop failure rates. - **License Fees**: Will fees decrease to $500 CAD per site, as recommended by the Standing Committee on Agriculture and Agri-Food? Lower fees would reduce barriers for small-scale farmers. - **Approval Timelines**: Will Health Canada commit to 30-day license approvals, or maintain the current 60-90 day standard? Faster approvals would allow farmers to plant during optimal windows. - **CBD Pathways**: Will Health Canada establish a simplified notification system for low-dose CBD products, or maintain the current natural health product approval process? A streamlined pathway could unlock a $200 million CAD domestic CBD market. - **Security Requirements**: Will outdoor hemp fields require fencing and surveillance, or will Health Canada formally exempt them? Eliminating security requirements would reduce compliance costs. Scenarios range from incremental adjustments to comprehensive reform. A conservative outcome would reduce fees to $1,000 CAD, accelerate approvals to 45 days, and clarify security exemptions for outdoor fields. A progressive outcome would adopt delta-9-THC testing, reduce fees to $500 CAD, establish 30-day approvals, and create a simplified CBD pathway. Industry observers expect moderate reform. Health Canada has historically prioritized caution over industry preferences, particularly on THC thresholds. However, pressure from provincial governments and the Standing Committee on Agriculture and Agri-Food may push the department toward more substantial changes. International developments will influence Canada's decisions. If the United States adopts 1% total THC thresholds nationally, Canada may face pressure to harmonize. Conversely, if European Union countries maintain 0.3% limits, Canada may retain its current threshold to preserve export market access. The 2025 federal election, scheduled for October 2025, could affect the review timeline. A change in government might alter priorities, though hemp regulation has enjoyed bipartisan support. Both Liberal and Conservative parties have endorsed regulatory streamlining for agricultural sectors.

Further Reading

• Cannabis Act (S.C. 2018, c. 16) — Full text of Canada's primary cannabis legislation: https://laws-lois.justice.gc.ca/eng/acts/C-24.5/
• Cannabis Regulations (SOR/2018-144) — Detailed regulatory requirements including Part 14 on industrial hemp: https://laws-lois.justice.gc.ca/eng/regulations/SOR-2018-144/
• Health Canada Industrial Hemp Licensing Guide — Official guidance for license applicants: https://www.canada.ca/en/health-canada/services/drugs-medication/cannabis/producing-selling-hemp/about-hemp-canada-hemp-industry/hemp-licensing-guide.html
• Standing Committee on Agriculture and Agri-Food, "Growing Forward: Opportunities for Canada's Hemp Industry" (March 2024) — Parliamentary report with reform recommendations: https://www.ourcommons.ca/DocumentViewer/en/44-1/AGRI/report-12/
• Agriculture and Agri-Food Canada, "Industrial Hemp Sector Profile" (June 2022) — Market analysis and regulatory assessment: https://agriculture.canada.ca/en/sector/horticulture/reports/industrial-hemp-sector-profile-2022
• Canadian Hemp Trade Alliance — Industry association representing farmers and processors: https://www.canadianhemp.ca/
• List of Approved Cultivars for Industrial Hemp — Canadian Food Inspection Agency registry of certified seed varieties: https://www.inspection.gc.ca/plant-varieties/plants-with-novel-traits/approved-under-review/hemp/eng/1330375945581/1330376021577
• 1961 Single Convention on Narcotic Drugs — International treaty governing cannabis control: https://www.unodc.org/unodc/en/treaties/single-convention.html
• U.S. Agricultural Improvement Act of 2018 (Farm Bill) — U.S. legislation that legalized hemp, providing comparative context: https://www.congress.gov/bill/115th-congress/house-bill/2
• Hemp Genetics International — Leading Canadian hemp seed producer and genetics developer: https://hempgenetics.com/